Correlation Between Medipharm Labs and Decibel Cannabis

Can any of the company-specific risk be diversified away by investing in both Medipharm Labs and Decibel Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medipharm Labs and Decibel Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medipharm Labs Corp and Decibel Cannabis, you can compare the effects of market volatilities on Medipharm Labs and Decibel Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medipharm Labs with a short position of Decibel Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medipharm Labs and Decibel Cannabis.

Diversification Opportunities for Medipharm Labs and Decibel Cannabis

-0.36

Correlation Coefficient

Medipharm Labs  Decibel Cannabis

Very good diversification

The 3 months correlation between Medipharm and Decibel is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and Decibel Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Decibel Cannabis and Medipharm Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medipharm Labs Corp are associated (or correlated) with Decibel Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Decibel Cannabis has no effect on the direction of Medipharm Labs i.e., Medipharm Labs and Decibel Cannabis go up and down completely randomly.

Pair Corralation between Medipharm Labs and Decibel Cannabis

Assuming the 90 days trading horizon Medipharm Labs Corp is expected to under-perform the Decibel Cannabis. But the stock apears to be less risky and, when comparing its historical volatility, Medipharm Labs Corp is 1.36 times less risky than Decibel Cannabis. The stock trades about -0.04 of its potential returns per unit of risk. The Decibel Cannabis is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  7.00  in Decibel Cannabis on September 15, 2024 and sell it today you would earn a total of  0.00  from holding Decibel Cannabis or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Medipharm Labs Corp  vs.  Decibel Cannabis

Medipharm Labs Corp

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Medipharm Labs Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Medipharm Labs displayed solid returns over the last few months and may actually be approaching a breakup point.

Decibel Cannabis

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Decibel Cannabis are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Decibel Cannabis showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Medipharm Labs and Decibel Cannabis

The main advantage of trading using opposite Medipharm Labs and Decibel Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medipharm Labs position performs unexpectedly, Decibel Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decibel Cannabis will offset losses from the drop in Decibel Cannabis' long position.

The idea behind Medipharm Labs Corp and Decibel Cannabis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.